This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
Deals and Financings Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate against Human Epidermal Growth Factor Receptor 3 (HER3) to...
Assertio Holdings (NASDAQ:ASRT) stands at a pivotal juncture in its history. A mere 3.5 years ago, Assertio’s portfolio was heavily reliant on ZIPSOR and...
By Peter Bourbeau and Margaret Vitrano Moving to the Middle as Growth Slows Market Overview Equities took a breather in the third quarter, pressured...
After Coke (KO) and Pepsi (PEP), Keurig Dr Pepper (NASDAQ:KDP) is the third-largest beverage company in North America, with annual revenues of approximately $14...
By Robert Feitler and Dmitry Khaykin Risk Mitigation Is the Other Half of Upside Participation Market Overview U.S. equities pulled back from highs reached...
Focused on the Fundamentals In a recent Management Meeting, PayPal (NASDAQ:PYPL) executives went into details on some key business initiatives that they are rolling...
The Oakmark Global Fund (MUTF:OAKGX, the “Fund”) returned 26.88% for the fiscal year ended September 30, 2023, outperforming its benchmark, the MSCI World Index...
The Oakmark Global Select Fund (OAKWX, the “Fund”) returned 27.70% for the fiscal year ended September 30, 2023, outperforming the MSCI World Index (net),...